Indication
Cardiovascular Death
1 clinical trial
2 products
Clinical trial
Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors and the Risk of Cardiovascular Events Among Patients With Type 2 Diabetes: a Multicenter Cohort StudyStatus: Completed, Estimated PCD: 2019-10-01